|BrainStorm Featured on CNBC |
MarketWatch (press release)
... a developer of innovative stem cell technologies for neurodegenerative disorders, announced that NurOwn(TM), its autologous stem cell therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's Disease, was profiled yesterday on CNBC.
See all stories on this topic »
Post a Comment